Skip to main content
ADMQ
OTC Trade & Services

ADM Endeavors Q2 10-Q: Losses, a Toxic Convertible Note, and CEO Credit Lines

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.036
Mkt Cap
$5.723M
52W Low
$0.011
52W High
$0.051
52W Position info
227% above low
Off High info
29% below high
Rel. Volume
Market data snapshot near publication time

ADMQ has more than doubled off its 52-week low of $0.011.

Summary

ADM Endeavors' Q2 10-Q reveals a going concern warning, a new toxic convertible note, CEO credit lines, a CFO change, and a $20 million equity line with GHS Investments.


Key Events · Earnings and Guidance · ADMQ

  • Going Concern Warning Reiterated

    A working capital deficit of $470,072 and a net loss of $70,013 for six months raise substantial doubt about the company's ability to continue as a going concern.

  • New Toxic Convertible Note

    Issued a $220,000 convertible note to Womack Capital Partners with a conversion price as low as $0.02 per share, creating a derivative liability of $117,628.

  • CEO Credit Lines

    Entered two revolving credit agreements with the CEO totaling $640,000, with $580,000 drawn and secured by company assets.

  • CFO Transition

    Alex Archer resigned as CFO and Calvin Tsang was appointed on June 15, 2026, with an annual salary of $120,000.


Analysis · ADMQ · Trade & Services

The going concern warning now comes with a new $220,000 convertible note that carries a variable conversion price as low as $0.02 per share, a derivative liability of $117,628, and two CEO credit lines totaling $640,000. Adding to the uncertainty, the CFO change raises governance concerns. The equity financing agreement with GHS Investments allows up to $20 million in deeply discounted share sales, creating significant dilution risk for existing holders.

At the time of this filing, ADMQ was trading at $0.04 on OTC in the Trade & Services sector, with a market capitalization of approximately $5.7M. The 52-week trading range was $0.01 to $0.05. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADMQ - Latest Insights

ADMQ
Jul 21, 2026, 8:09 AM EDT
Source: EQS
Importance Score:
7
ADMQ
May 15, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
9
ADMQ
Apr 06, 2026, 6:18 PM EDT
Filing Type: 4
Importance Score:
7
ADMQ
Apr 06, 2026, 8:06 AM EDT
Source: EQS
Importance Score:
8
ADMQ
Apr 01, 2026, 8:07 AM EDT
Source: EQS
Importance Score:
7